- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 98.28M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $281.9M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $251.78M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $605.59M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $731.68M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.32B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.44B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $2.43B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.07B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.47B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.96B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.1B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $427.29M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 99.11M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $32.44M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$242.08M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $961.19M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $859.34M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.37 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.38 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $127M |
| Net Income | Q1 2025 · Mar 31, 2024 | $36.12M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $34.91M |
| Revenue | Q1 2025 · Mar 31, 2024 | $359.48M |